Director/PDMR Dealings & Issue of Equity
The Company has been informed that Mark Scanlon, Chief Executive Officer, exercised options over 38,683 ordinary shares of 5p each in the Company (“Ordinary Shares”) at nil exercise cost. These options had been granted under the Company’s Long Term Incentive Plan (“LTIP”), as detailed in its RNS released on 30 November 2017.
Following the exercise, he sold 18,500 Ordinary Shares to cover the associated tax charges at a price of £3.95 per share on 3 April 2018.
Following this transaction, Mark Scanlon has increased his total interest in shares to 152,529 Ordinary Shares representing 0.494% of the issued ordinary share capital of the Company.
Furthermore, the Company has also been informed that Mike Dugdale, Chief Financial Officer exercised options previously granted under the LTIP over 46,351 Ordinary Shares at nil exercise cost, which he subsequently sold at a price of £3.95 per share on 3 April 2018. Following this transaction, Mike Dugdale has a total interest in 68,548 Ordinary Shares, including his wife’s holding of 13,671 shares, representing 0.222% of the issued ordinary share capital of the Company.
The Company has allotted a total of 85,034 new Ordinary Shares of 5p each ("New Shares") in connection with the above exercises. Application has been made for the New Shares to be admitted to trading on AIM ("Admission") and it is expected that Admission will take place on 10 April 2018.
Following Admission, the Company will have 30,884,925 Ordinary Shares in issue. The Company does not hold any Ordinary Shares in treasury. Therefore the total number of Ordinary Shares in the Company with voting rights is 30,884,925.
Further detail is provided below in accordance with Article 19.3 of the EU Market Abuse Regulation.
Further details can be found here.
Get all the latest news and information from us by signing up to our newsletter.